2022 AMI Online Salon

AI Will Revolutionize Medicine

Project Detail

  • Entrant Name:  Cameron Slayden
  • Other Contributors Stephen Boyd
  • Client: Generate Biomedicines
  • Copyright: Generate Biomedicines, Inc., 2021
  • Medium/software used: Cinema 4D/After Effects
  • Final presentation format: Web
  • Primary Audience: Investors, Journalists, General Audiences

Project Description

Generate Biomedicines has developed artificial intelligence capable of designing therapeutics that will change medicine as we know it. AI Will Revolutionize Medicine positions their brand identity as a leader in this new field, with the intention of attracting investors, generating media buzz, and conveying the company’s mission at a glance. Fidelity to structural accuracy in the environments and the molecules themselves is critical to appeal to Ph.D-level due-diligence investigators, while uncomplicated verbiage and a familiar electron-microscope styles keep the visuals and message accessible to general audiences. Stark, black-and-white “calculation space,” representing the results of machine learning technology, is juxtaposed with rich, complicated and colorful biological scenes in which the resulting therapeutics play their roles. A tone of new beginnings and discovery is key in conveying the role Generate Biomedicines, and companies like it, will play in the future of healthcare and the eradication of disease.